Bionic Pancreas in CFRD
Public ClinicalTrials.gov record NCT06449677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Trial of the Insulin-only Bionic Pancreas in Cystic Fibrosis Related Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.
Study identification
- NCT ID
- NCT06449677
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 14 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2024
- Primary completion
- Sep 29, 2026
- Completion
- Mar 29, 2027
- Last update posted
- Jun 23, 2026
2024 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Colorado-Barbara Davis Center for Diabetes | Aurora | Colorado | 80045 | Recruiting |
| Yale University School of Medicine | New Haven | Connecticut | 06511 | Recruiting |
| Emory University | Atlanta | Georgia | 30329 | Recruiting |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | Recruiting |
| Johns Hopkins University School of Medicine | Baltimore | Maryland | 21287 | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| University of Minnesota | Minneapolis | Minnesota | 55455 | Recruiting |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | Recruiting |
| Columbia University Medical Center | New York | New York | 10032 | Recruiting |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106 | Recruiting |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Completed |
| UT Southwestern Medical Center | Dallas | Texas | 75235 | Recruiting |
| Baylor College of Medicine | Houston | Texas | 77030 | Recruiting |
| University of Texas Health San Antonio | San Antonio | Texas | 78207 | Recruiting |
| University of Utah | Salt Lake City | Utah | 84132 | Recruiting |
| University of Virginia-Center for Diabetes Technology | Charlottesville | Virginia | 22903 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cystic Fibrosis-related Diabetes trials
Other public records listing Cystic Fibrosis-related Diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07688070: Verapamil Effect in Cystic Fibrosis-related Dysglycemia Not yet recruiting
- NCT07102043: Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD) Recruiting
- NCT04530383: Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function Recruiting
- NCT06995651: Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis Recruiting
- NCT05463289: ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2 Recruiting
- NCT06837181: Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06449677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2026 · Synced Jul 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06449677 live on ClinicalTrials.gov.